Prior Authorization Changes Postponed for Musculoskeletal Procedures and Pain Management, Molecular and Genomic Testing, and Radiation Oncology
November 29, 2022
To: All Providers
Contracts affected: Commercial, Medicare Advantage.
We are postponing the authorization requirement changes for some musculoskeletal (MSK) procedures and interventional pain management, molecular and genomic testing, and radiation oncology services that we announced last month.
The requirement updates, which will be managed by eviCore, will take effect late Q1 or early Q2. For now, please continue to request authorization through your regular workflow.
Educational webinars will be offered in advance of implementation. We will send registration information and webinar dates prior to implementation of the eviCore program.